Member Info for woody2002

Happens all the time mate. Dunno why tbh

Is going on with this SP? I was invested here quite a while ago. Probably lucky to sell up at 21p iirc for a small profit. Seriously considering buying tomorrow.

If a contract was signed it needs to be RNSd they can't withhold it as its price sensitive.

I'm not sure how the rain affects the field work here but GH CEO of GGP has stated their attention will need to shift from end of NOV due to the temperatures being too high for the team to be out drilling etc. suppose it depends which site and where in OZ you are.

Next time you try correct someone try being right ;P

You cant read. Or interpret infirmaton. Company RNSd information to let us know as John said. Why would they leave it and let us know we're nearly there? That eould not require an RNS which costs £££s

Also "the current cohort has already received the escalated dose. This marks the point that VAL201 entered the concluding stages of the Phase l/ll clinical trial. The VAL201 compound has already demonstrated consistent safety and tolerability and signs of activity in previous patients treated with LOWER dosages" they clearly highlight the signs of activity in lower doses. No word on higher doses why? Cos its just started!

10m to 100m dividends? Am I reading that right?

How would that offer a saving? Isnt there just a fee per RNS?

Mer Decembers RNS was for recieving approval, agreed? Then in todays RNS they stated the intervening period was for screening amd recruitment (I think thisnis were u are getting lost). Then todays RNS was to announce increased dosage being administered. As it clearly states "This signifies the concluding stages" hence the need for an RNS... otherwise the RNS is a repeat and not required. Or you believe they released the RNS to tell us they're nearly finished?????? So to put it another way. what is the intervening screenng and recruiting period ? when did that happen? The day they got approval in December. They just started throwing more drugs at fold hahahaha. The RNS was to announc3 the increasd dosage for which approval was received in December.

Mer you shouldn't imply people should read slowly when you're not understanding the information. Makes you look silly man!

Roses....."I am delighted that this trial is ongoing and reaching the FINAL stages and I look forward to the trial further impacting positively on the lives of current and future patients".

We got the RNS stating the dosage increase signifies the concluding stages its the whole point. Or do u think the RNS which costs money is to say were nearly finished lol. You are confused mate. It clearly says approval was announced 18th December not increased dosage.

Mer it clearly states they announced approval in December! are you implying they started the increased dosage then? the intervening period between then and now was used for screening and selection of suitable candidates. The RNS states 201 in concluding stages dated today!! Quoting "The current cohort has already received the escalated dose. THIS marks the point that VAL201 entered the concluding stages of the Phase l/ll clinical trial"

Roses whats ur point? Theres an imaginary additional stage to the trial that you just thought up. Go educate yourself...

Mer - this stage of the trial follows approval received from the Medicines and Healthcare products Regulatory Agency ("MHRA") to escalate VAL201 dosing (announced by the Company on18 December 2017). In the intervening period, the Company has geared up the compound supply chain to meet increased demand for the drug, as a result of the higher dosage TO BE administered. UCLH has spent the period both screening and recruiting patients who are eligible to enter this stage of the study.....they have started administering the drug which signifies the concluding period... between Decembers RNS and now they've recruited and screened patients suitable. The increased dosage is the start of the concluding period mate.

Means the same thing, give your brain a rest. This is not a results RNS its to notify the market they're moving to increased dosage.

Possible shrinkage of tumours shirley? Results will be ages away no doubt. Im as excited for 201/301 as I am on 401. Nowhere near commercialisation but they appear to be effective! GLA

Really keen to see how the results pan out for this with regards to preventing tumour growth. If there's good results with the lower dosage already!

This stage of the trial follows approval received from the Medicines and Healthcare products Regulatory Agency ("MHRA") to escalate VAL201 dosing (announced by the Company on18 December 2017). In the intervening period, the Company has geared up the compound supply chain to meet increased demand for the drug, as a result of the higher dosage to be administered. UCLH has spent the period both screening and recruiting patients who are eligible to enter this stage of the study. The current cohort has already received the escalated dose. This marks the point that VAL201 entered the concluding stages of the Phase l/ll clinical trial. The VAL201 compound has already demonstrated consistent safety and tolerability and signs of activity in previous patients treated with lower dosages.